ARQT - long - momentum and catalyst play

Feb 9

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

This is not a financial advice!

Recent block buys

Upcoming catalyst in July 2024

Medium float of 78.91M
Short float 26.40%

ER is on the 14th of February - keep that in mind

We might see a correction to 4-5 level, where is a perfect buy zone

With enough volume and good ER we could break the last high zone 7.0 - 7.3

SL depends on your entry. If u enter now in the 6.5s SL under 5.3

If u enter in the 4-5 zone SL under 3.0

Most info on the chart.

Trade carefully!

Feb 16

Note

booom

Mar 1

Note

massive

Mar 20

Note

Wednesday March 20, 2024
04:55:53PM
ARQT
Block Trade: ARQT 547,809 @ $10.80 above ask of 10.79
Signals
Monday March 18, 2024
05:39:19PM
ARQT
Block Trade: ARQT 579,186 @ $10.235
Signals
Friday March 15, 2024
04:50:36PM
ARQT
Block Trade: ARQT 541,277 @ $10.66
Signals
Thursday March 7, 2024
05:28:43PM
ARQT
Block Trade: ARQT 847,755 @ $10.38
Signals
Tuesday March 5, 2024
04:58:32PM
ARQT
Block Trade: ARQT 888,729 @ $10.90 at the bid
Signals
Tuesday February 20, 2024
04:51:36PM
ARQT
Block Trade: ARQT 510,799 @ $9.48 at the bid
Signals
Monday February 12, 2024
04:53:49PM
ARQT
Block Trade: ARQT 538,863 @ $6.69

May 19

Trade closed: target reached

hit 13.2

Jun 14

Note

looks good for a breakout imo